Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE-013

Vincent Ribrag, David E. Avigan, Damian J. Green, Trisha Wise-Draper, Juan G. Posada, Ravi Vij, Ying Zhu, Mohammed Z.H. Farooqui, Patricia Marinello, David S. Siegel

Research output: Contribution to journalLetterpeer-review

47 Scopus citations
Original languageEnglish
Pages (from-to)e41-e44
JournalBritish Journal of Haematology
Issue number3
StatePublished - Aug 2019


  • PD-1 (PDCD1)
  • multiple myeloma
  • pembrolizumab

Cite this